Smoking history and severe atrophic gastritis assessed by pepsinogen are risk factors for the prevalence of synchronous gastric cancers in patients with gastric endoscopic submucosal dissection: a multicenter prospective cohort study

J Gastroenterol. 2023 May;58(5):433-443. doi: 10.1007/s00535-023-01967-y. Epub 2023 Feb 14.

Abstract

Background: No studies have evaluated the relationship between lifestyle and synchronous gastric cancers (SGCs) in patients with endoscopic submucosal dissection (ESD) for early gastric cancers (EGCs). Using data from the Tohoku gastrointestinal (GI) study, we aimed to identify factors associated with SGCs.

Methods: Tohoku GI study is a multicenter prospective cohort study investigating the relationship between lifestyle and metachronous gastric cancers. Patients who had a schedule to undergo ESD for primary EGCs were enrolled. We used logistic regression analysis to examine the relationship of 15 candidate factors, including lifestyle, with the prevalence of SGCs in this study.

Results: Of 850 patients between 2016 and 2019, 16.0% (136 patients) had SGCs. In multivariate analysis, smoking history (odds ratio [OR], 1.93; p = 0.048) and severe atrophic gastritis assessed by pepsinogen (OR, 1.92; p = 0.004) were risk factors for the prevalence of SGCs. Regarding smoking, current smoking (OR, 2.33; p = 0.021), but not former smoking (OR, 1.76; p = 0.098), was a significant risk factor for its prevalence. In the stratified analysis, severe atrophic gastritis assessed by pepsinogen was a risk factor in patients without Helicobacter pylori (H. pylori) eradication (OR, 2.10; p = 0.002), but not a risk factor in those with H. pylori eradication (OR, 0.75; p = 0.737).

Conclusion: Smoking history was a risk factor for the prevalence of SGCs in patients with ESD for EGCs, and severe atrophic gastritis assessed by pepsinogen was also a risk factor when H. pylori was not eradicated.

Keywords: Atrophic gastritis; Smoking; Synchronous gastric cancers.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Endoscopic Mucosal Resection* / adverse effects
  • Gastritis, Atrophic* / epidemiology
  • Helicobacter Infections* / complications
  • Helicobacter Infections* / epidemiology
  • Helicobacter pylori*
  • Humans
  • Pepsinogen A
  • Prevalence
  • Prospective Studies
  • Risk Factors
  • Smoking / adverse effects
  • Smoking / epidemiology
  • Stomach Neoplasms* / epidemiology
  • Stomach Neoplasms* / etiology
  • Stomach Neoplasms* / surgery

Substances

  • Pepsinogen A